Harnessing SARS‐CoV‐2‐specific CD8<sup>+</sup> T cells to kill target tumor cells for cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Harnessing SARS‐CoV‐2‐specific CD8⁺ T cells to kill target tumor cells for cancer immunotherapy

Published:2023-10-19 Issue:1 Volume:44 Page:173-177
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Jung Keunok¹,Ko Deok‐Han²,Jang Jeong‐Yun²,Kim Young Rong³,Heo Jung Yeon³,Kim Yong‐Sung¹²^ORCID

Affiliation:

1. Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon Republic of Korea

2. Department of Molecular Science and Technology Ajou University Suwon Republic of Korea

3. Department of Infectious Diseases Ajou University School of Medicine Suwon Republic of Korea

Funder

Ministry of Health and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12497

Reference10 articles.

1. SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals

2. Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells

3. Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

4. Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy

5. Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the cytotoxicity of immunotoxins by facilitating their dissociation from target receptors under the reducing conditions of the endocytic pathway;International Journal of Biological Macromolecules;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3